Last reviewed · How we verify
NCT06563154
Are Exercise Capacity and Physical Fitness Related With Quality of Life, Physical Activity, Cognitive Health and Health Literacy in Dyslipidemia
trial testing Exercise Capacity Assessment in Dyslipidemias in 65 participants. Completed in 30 December 2024.
15 December 2024
Quick facts
| Lead sponsor | Çankırı Karatekin University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 65 |
| Start date | 20 August 2024 |
| Primary completion | 15 December 2024 |
| Estimated completion | 30 December 2024 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Exercise Capacity Assessment
- Physical Fitness Assessment
- Quality of Life Assessment
- Physical Activity Assessment
- Cognitive Health Assessment
- Health Literacy Assessment
Conditions studied
- Dyslipidemias — all drugs for Dyslipidemias →
Sponsor
Çankırı Karatekin University
Who can join
Adults 18 to 65, any sex, with Dyslipidemias. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
There is insufficient literature explaining the relationship between exercise capacity and physical fitness of dyslipidemia patients and quality of life, cognitive status and health literacy. Our aim with this study is to provide more information to the scientific literature about the relationship between exercise capacity and physical fitness and quality of life and health literacy in dyslipidemia patients.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Impact of physical activity, health literacy and cognitive health on quality of life in dyslipidemia: an observational study.
Ozdemir F, Saglam M, Uyaroglu OA, Vardar Yagli N. · · 2025 · PMID 41083504 · DOI 10.1038/s41598-025-02223-4
Verify or expand the search:
- PubMed search for NCT06563154
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Exercise Capacity Assessment
Trials testing the same drug.
- NCT07306468 — Effects of Schizophrenia and Bipolar Disorder on Exercise Capacity, Pulmonary Function, and Quality of Life · recruiting
Other recruiting trials for Dyslipidemias
Currently open trials in the same condition.
- NCT07308314 — Taining Golden Lake Comprehensive Chronic Disease Management Initiative · recruiting
- NCT06526273 — PILI 'Āina Household · NA · recruiting
- NCT06797401 — Phase 2 Trial Evaluating the Efficacy and Safety of RBD5044 in Patients With Mixed Dyslipidemia · Phase 2 · recruiting
- NCT06380322 — Military Health and Nutrition Examination Study · recruiting
- NCT06183307 — Effects of Nattokinase on Inflammation and Cardiovascular Risk Markers in Patients With Dyslipidemia · NA · recruiting
Other Çankırı Karatekin University trials
Trials by the same sponsor.
- NCT07326267 — School-Based Sensory Processing and Daily Living Skills-Focused Occupational Therapy Program · NA · not yet recruiting
- NCT07512544 — Building Sustainability Competencies in Future Nurses · NA · not yet recruiting
- NCT07266870 — Effect of CORE on Knowledge and Attitude Levels Regarding Pain Assessment · NA · completed
- NCT07306468 — Effects of Schizophrenia and Bipolar Disorder on Exercise Capacity, Pulmonary Function, and Quality of Life · recruiting
- NCT07207655 — Knowledge and Beliefs of Hearing Impaired Individuals Regarding Human Papillomavirus (HPV) · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06563154 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Çankırı Karatekin University
- Last refreshed: 10 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06563154.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing